Table 1 Primary cancer characteristics and pre-existing disease of patients at baseline
From: Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
Variable | Patients [cases (%)] |
|---|---|
Total | 527 |
Male | 348 (66.0) |
Primary cancer | |
 Colorectal | 378 (71.7) |
 Gastric | 123 (23.3) |
 Head and neck | 15 (2.9) |
 Esophageal | 6 (1.1) |
 Breast | 4 (0.8) |
 Nasopharyngeal | 1 (0.2) |
Cancer stage | |
 I | 2 (0.4) |
 II | 105 (20.0) |
 III | 249 (47.2) |
 IV | 153 (29.0) |
 Not available | 18 (3.4) |
Pre-existing disease | |
 Hypertension | 106 (20.1) |
 Diabetes | 29 (5.5) |
 Cardiac disease | 13 (2.5) |
 Hyperlipidemia | 4 (0.8) |
Surgical history | 415 (78.7) |
 Radical | 338 (64.1) |
 Palliative | 57 (10.8) |
 Unknown | 20 (3.8) |
Treatment history | 176 (33.4) |
 Chemotherapy | 118 (22.4) |
 Radiotherapy | 32 (6.1) |
 Chemotherapy and radiotherapy | 26 (4.9) |